Gefapixant Citrate
Spécifications
2310299-91-1Numéro CAS
5-(2,4-diaminopyrimidin-5-yl)oxy-2-methoxy-4-propan-2-ylbenzenesulfonamide;2-hydroxypropane-1,2,3-tricarboxylic acidNom IUPAC
C20H27N5O11SFormule chimique
545.5 g/molMasse molaire
Gefapixant citrate; 2310299-91-1; DFK0FC2VVV; MK-7264; AF-219 CITRATE; MK7264 CITRATE; MK-7264 CITRATE; MK7264; RefChem:922135; Gefapixant citrate [USAN]; Gefapixant (citrate); UNII-DFK0FC2VVV; Benzenesulfonamide, 5-((2,4-diamino-5-pyrimidinyl)oxy)-2-methoxy-4-(1-methylethyl)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1); 5-((2,4-Diaminopyrimidin-5-yl)oxy)-2-methoxy-4-(propan-2-yl)benzenesulfonamide 2-hydroxypropane-1,2,3-tricarboxylate (1:1); 5-[(2,4-Diamino-5-pyrimidinyl)oxy]-2-methoxy-4-(1-methylethyl)-benzenesulfonamide, 2-hydroxy-1,2,3-propanetricarboxylate (1:1); 5-[(2,4-Diaminopyrimidin-5-yl)oxy]-2-methoxy-4-(propan-2-yl)benzenesulfonamide 2-hydroxypropane-1,2,3-tricarboxylate (1:1); Lyfnua (TN); Gefapixant citrate [WHO-DD]; orb1686191; CHEMBL4594278; Gefapixant citrate (JAN/USAN); GEFAPIXANT CITRATE [JAN]; SCHEMBL29369007; GLXC-25966; HY-101588A; AC-38205; DA-63728; CS-0377571; D11693; T63846; 5-(2,4-diaminopyrimidin-5-yl)oxy-2-methoxy-4-propan-2-ylbenzenesulfonamide citrateSynonymes